FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Stock Price Up 0.5% – Here’s What Happened

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was up 0.5% during trading on Monday . The company traded as high as $40.13 and last traded at $40.25. Approximately 21,075 shares changed hands during mid-day trading, The stock had previously closed at $40.05.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Up 0.5 %

The stock has a 50-day moving average of $39.77 and a 200 day moving average of $39.30. The stock has a market cap of $196.40 million, a PE ratio of 23.49 and a beta of 0.46.

Institutional Investors Weigh In On FT Vest U.S. Equity Deep Buffer ETF – October

Several hedge funds have recently added to or reduced their stakes in the business. Creative Financial Designs Inc. ADV raised its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 40.6% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 1,326 shares of the company’s stock valued at $52,000 after buying an additional 383 shares during the last quarter. AlphaMark Advisors LLC grew its holdings in FT Vest U.S. Equity Deep Buffer ETF – October by 223.4% during the fourth quarter. AlphaMark Advisors LLC now owns 1,520 shares of the company’s stock worth $60,000 after acquiring an additional 1,050 shares during the period. Sunbelt Securities Inc. raised its position in FT Vest U.S. Equity Deep Buffer ETF – October by 129.7% during the third quarter. Sunbelt Securities Inc. now owns 3,515 shares of the company’s stock valued at $137,000 after acquiring an additional 1,985 shares in the last quarter. Finally, Arkadios Wealth Advisors acquired a new stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October during the 4th quarter worth approximately $214,000.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.